Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Bio-Techne (TECH) over the last 10 years, with Q2 2025 value amounting to $134000.0.

  • Bio-Techne's Gains from Sales and Divestitures rose 387.6% to $134000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $134000.0, marking a year-over-year increase of 387.6%. This contributed to the annual value of $134000.0 for FY2025, which is 387.6% up from last year.
  • Bio-Techne's Gains from Sales and Divestitures amounted to $134000.0 in Q2 2025, which was up 387.6% from $129000.0 recorded in Q2 2024.
  • In the past 5 years, Bio-Techne's Gains from Sales and Divestitures registered a high of $206000.0 during Q2 2021, and its lowest value of $123000.0 during Q2 2023.
  • In the last 5 years, Bio-Techne's Gains from Sales and Divestitures had a median value of $134000.0 in 2025 and averaged $147400.0.
  • As far as peak fluctuations go, Bio-Techne's Gains from Sales and Divestitures soared by 30392.16% in 2021, and later crashed by 2961.17% in 2022.
  • Quarter analysis of 5 years shows Bio-Techne's Gains from Sales and Divestitures stood at $206000.0 in 2021, then fell by 29.61% to $145000.0 in 2022, then dropped by 15.17% to $123000.0 in 2023, then increased by 4.88% to $129000.0 in 2024, then rose by 3.88% to $134000.0 in 2025.
  • Its last three reported values are $134000.0 in Q2 2025, $129000.0 for Q2 2024, and $123000.0 during Q2 2023.